223 related articles for article (PubMed ID: 32457045)
1. Regulation of poly(a)-specific ribonuclease activity by reversible lysine acetylation.
Dejene EA; Li Y; Showkatian Z; Ling H; Seto E
J Biol Chem; 2020 Jul; 295(30):10255-10270. PubMed ID: 32457045
[TBL] [Abstract][Full Text] [Related]
2. Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.
Moon DH; Segal M; Boyraz B; Guinan E; Hofmann I; Cahan P; Tai AK; Agarwal S
Nat Genet; 2015 Dec; 47(12):1482-8. PubMed ID: 26482878
[TBL] [Abstract][Full Text] [Related]
3. A Polyadenylation-Dependent 3' End Maturation Pathway Is Required for the Synthesis of the Human Telomerase RNA.
Nguyen D; Grenier St-Sauveur V; Bergeron D; Dupuis-Sandoval F; Scott MS; Bachand F
Cell Rep; 2015 Dec; 13(10):2244-57. PubMed ID: 26628368
[TBL] [Abstract][Full Text] [Related]
4. TOE1 acts as a 3' exonuclease for telomerase RNA and regulates telomere maintenance.
Deng T; Huang Y; Weng K; Lin S; Li Y; Shi G; Chen Y; Huang J; Liu D; Ma W; Songyang Z
Nucleic Acids Res; 2019 Jan; 47(1):391-405. PubMed ID: 30371886
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.
Shukla S; Schmidt JC; Goldfarb KC; Cech TR; Parker R
Nat Struct Mol Biol; 2016 Apr; 23(4):286-92. PubMed ID: 26950371
[TBL] [Abstract][Full Text] [Related]
6. Disruption of Telomerase RNA Maturation Kinetics Precipitates Disease.
Roake CM; Chen L; Chakravarthy AL; Ferrell JE; Raffa GD; Artandi SE
Mol Cell; 2019 May; 74(4):688-700.e3. PubMed ID: 30930056
[TBL] [Abstract][Full Text] [Related]
7. Impaired telomere integrity and rRNA biogenesis in PARN-deficient patients and knock-out models.
Benyelles M; Episkopou H; O'Donohue MF; Kermasson L; Frange P; Poulain F; Burcu Belen F; Polat M; Bole-Feysot C; Langa-Vives F; Gleizes PE; de Villartay JP; Callebaut I; Decottignies A; Revy P
EMBO Mol Med; 2019 Jul; 11(7):e10201. PubMed ID: 31273937
[TBL] [Abstract][Full Text] [Related]
8. Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease.
Boyraz B; Moon DH; Segal M; Muosieyiri MZ; Aykanat A; Tai AK; Cahan P; Agarwal S
J Clin Invest; 2016 Sep; 126(9):3377-82. PubMed ID: 27482890
[TBL] [Abstract][Full Text] [Related]
9. The RNase PARN Controls the Levels of Specific miRNAs that Contribute to p53 Regulation.
Shukla S; Bjerke GA; Muhlrad D; Yi R; Parker R
Mol Cell; 2019 Mar; 73(6):1204-1216.e4. PubMed ID: 30770239
[TBL] [Abstract][Full Text] [Related]
10. PARN and TOE1 Constitute a 3' End Maturation Module for Nuclear Non-coding RNAs.
Son A; Park JE; Kim VN
Cell Rep; 2018 Apr; 23(3):888-898. PubMed ID: 29669292
[TBL] [Abstract][Full Text] [Related]
11. Poly (A)-specific ribonuclease deficiency impacts oogenesis in zebrafish.
Nanjappa DP; De Saffel H; Kalladka K; Arjuna S; Babu N; Prasad K; Sips P; Chakraborty A
Sci Rep; 2023 Jun; 13(1):10026. PubMed ID: 37340076
[TBL] [Abstract][Full Text] [Related]
12. Poly (A)-specific ribonuclease (PARN): More than just "mRNA stock clearing".
Nanjappa DP; Babu N; Khanna-Gupta A; O'Donohue MF; Sips P; Chakraborty A
Life Sci; 2021 Nov; 285():119953. PubMed ID: 34520768
[TBL] [Abstract][Full Text] [Related]
13. From incomplete penetrance with normal telomere length to severe disease and telomere shortening in a family with monoallelic and biallelic PARN pathogenic variants.
Dodson LM; Baldan A; Nissbeck M; Gunja SMR; Bonnen PE; Aubert G; Birchansky S; Virtanen A; Bertuch AA
Hum Mutat; 2019 Dec; 40(12):2414-2429. PubMed ID: 31448843
[TBL] [Abstract][Full Text] [Related]
14. The H/ACA complex disrupts triplex in hTR precursor to permit processing by RRP6 and PARN.
Tseng CK; Wang HF; Schroeder MR; Baumann P
Nat Commun; 2018 Dec; 9(1):5430. PubMed ID: 30575725
[TBL] [Abstract][Full Text] [Related]
15. An integrated in silico approach to design specific inhibitors targeting human poly(a)-specific ribonuclease.
Vlachakis D; Pavlopoulou A; Tsiliki G; Komiotis D; Stathopoulos C; Balatsos NA; Kossida S
PLoS One; 2012; 7(12):e51113. PubMed ID: 23236441
[TBL] [Abstract][Full Text] [Related]
16. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
17. Loss of Human TGS1 Hypermethylase Promotes Increased Telomerase RNA and Telomere Elongation.
Chen L; Roake CM; Galati A; Bavasso F; Micheli E; Saggio I; Schoeftner S; Cacchione S; Gatti M; Artandi SE; Raffa GD
Cell Rep; 2020 Feb; 30(5):1358-1372.e5. PubMed ID: 32023455
[TBL] [Abstract][Full Text] [Related]
18. Modulation of poly(A)-specific ribonuclease (PARN): current knowledge and perspectives.
Balatsos NA; Maragozidis P; Anastasakis D; Stathopoulos C
Curr Med Chem; 2012; 19(28):4838-49. PubMed ID: 22834816
[TBL] [Abstract][Full Text] [Related]
19. The molecular genetics of the telomere biology disorders.
Bertuch AA
RNA Biol; 2016 Aug; 13(8):696-706. PubMed ID: 26400640
[TBL] [Abstract][Full Text] [Related]
20. PARN Modulates Y RNA Stability and Its 3'-End Formation.
Shukla S; Parker R
Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28760775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
